 |
|
|
| |
IM-PROVE I: Characterization of chronic hepatitis B (CHB) subjects with functional cure or HBV DNA suppression after completion of imdusiran plus short courses of pegylated interferon alfa-2a (IFN) and discontinuation of nucleos(t)ide analogue (NA) therapy
|
| |
| |
EASL 2025 May 7-10 Amsterdam
Pdf poster attsched
Download the PDF
|
| |
|
|
|
|
|
